Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The latest update of “Global Biosimilars Market” released by Stratagem Market Insights, forecasts further growth in the global supply and demand. The market report builds upon our previous iteration and the new release reinforces the sentiment that the 2021-2028 period is expected to be a promising period for the global Biosimilars Market.
Overview of the Biosimilars Market:
A biosimilar drug is any drug that is designed from or very similar to an authentic biological drug. There are two main areas in which this occurs. One is where the basic molecular structure of an authentic biological drug is mimicked and another is where a "substance" is mimicked that resembles an authentic drug.
Market Dynamics:
Approval and launch of new products is expected to propel growth of the global biosimilars market over the forecast period. For instance, in October 2021, The U.S. Food and Drug Administration approved Cyltezo, the first interchangeable biosimilar product to Humira for the treatment of certain inflammatory diseases. Similarly, in July 2021, Mylan Pharmaceuticals received the U.S Food and Drug Administration approval for Semglee (insulin glargine), the first interchangeable biosimilar insulin product for treating diabetes.
R&D of new products is expected to offer lucrative growth opportunities for players in the global biosimilars market. For instance, in August 2021, Biogen Inc. partnered with Bio-Thera Solutions, Ltd. for the development, manufacture and commercialization of BAT1806, a Phase 3 clinical-stage anti-interleukin-6 (IL-6) receptor monoclonal antibody that is a proposed biosimilar referencing ACTEMRA (tocilizumab).
Major players operating in the global biosimilars market are focused on approval and launch of new products to expand their product portfolio. For instance, in September 2021, The U.S. Food and Drug Administration approved Byooviz (ranibizumab-nuna) as the first biosimilar to Lucentis (ranibizumab injection) for the treatment of several eye diseases and conditions. Similarly, in February 2021, Sandoz Canada Inc. launched Hyrimoz (adalimumab), a biosimilar to Humira, for the treatment of rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn’s disease, ulcerative colitis, hidradenitis suppurative, psoriasis and adult uveitis.
Key Takeaways:
- Approval and launch of new products is expected to propel growth of the global biosimilars market over the forecast period. For instance, in April 2020, Merck & Co., Inc. launched trastuzumab biosimilar Ontruzant at a 15% discount to the biologic medicine Herceptin.
- Major players operating in the global biosimilars market are focused on approval and launch of new products to expand their product portfolio. For instance, in February 2020, Pfizer Inc. launched trastuzumab biosimilar to Herceptin for the treatment of human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
- Major players operating in the global biosimilars market include, Novartis AG, Pfizer Inc., Dr. Reddy's Laboratories Ltd., Amgen Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Fresenius SE & Co. KGaA, and STADA Arzneimittel AG.
Market Estimation:
The data processed and validated in secondary and primary research is analyzed to compute market estimation statistics. It involves market breakdown, bottom-up, and top-down research. Our research team considers macroeconomic factors to forecast a comprehensive statistical time series. Each data point is validated through the process data triangulation method to derive the final market estimation.
COVID-19 Impact:
The updated report, free extract available, comes with an option to access premium features that covers extensive past, current, and future data. Other valuable updates to the global Biosimilars Market report include a reviewed and refined pricing model for manufacturing and launch prices. The report incorporates new content to help give decision-makers key knowledge about the market and offers up-to-date forecasts accounting for the economic situation and impact of COVID-19.
Market Competition Assessment:
The Biosimilars Market is observed as the most diversified and competitive market comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are
- Novartis AG (Switzerland)
- Pfizer Inc. (US)
- Dr. Reddy's Laboratories Ltd. (India)
- Amgen Inc. (US)
- Eli Lilly and Company (US)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Fresenius SE & Co. KGaA (Germany)
- STADA Arzneimittel AG (Germany)
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2028. For the purpose of this study, Stratagem Market Insights has segmented the global Biosimilars Market report on the basis of Types, Applications, and Regions.
By Product Type, the market is primarily segmented into:
- Infliximab
- Trastuzumab
- Rituximab
- Adalimumab
- Other monoclonal antibodies (bevacizumab, cetuximab, ranibizumab, denosumab, and eculizumab)
By Applications, the market is segmented into:
- Oncology
- Inflammatory & autoimmune disorders
- Chronic diseases
- Blood disorders
- Growth hormone deficiency
- Infectious diseases
The report covers the following Regions:
- North America
- Latin America
- Europe
- Asia Pacific
- Africa
- Middle East
Primary Research Insights:
The process of primary research starts with the verification and validation of every detail obtained in secondary research. This is done with the help of industry experts and in-house analysts who check the authentication of the data. Stratagem Market Insights also ensures that our research is not restricted by certain boundaries, which is why we consult each individual in the value chain including raw materials suppliers, local vendors, wholesale dealers, distributors, etc. We also make sure that every detail provided in the document will hold a certain value and it will not be trivial information. Moreover, current market trends, growth opportunities, drivers, and restraints are computed in primary research only.
The Report Sheds Light on Various Aspects of the Market, Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- Which regions might see the demand maturing in certain segments in near future?
- Which government regulations might challenge the status of key regional markets?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Why You Should Buy This Report:
- The report provides an all-inclusive environment of the analysis for the market
- In-depth secondary research and primary interviews
- Impact of various social, political, and economic factors
- Porter’s Five Forces Analysis
- Competitive Landscape
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biosimilars Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Biosimilars Market Share by Application: 2021 VS 2028
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Biosimilars Market
1.6.1 How the Covid-19 is Affecting the Biosimilars Market
1.6.1.1 Biosimilars Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Biosimilars Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Biosimilars Market Perspective (2015-2028)
2.2 Biosimilars Market Growth Trends by Regions
2.2.1 Biosimilars Market Size by Regions: 2015 VS 2021 VS 2028
2.2.2 Biosimilars Market Historic Market Share by Regions (2015-2021)
2.2.3 Biosimilars Market Forecasted Market Size by Regions (2021-2028)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Biosimilars Market Growth Strategy
2.3.6 Primary Interviews with Key Biosimilars Market Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Biosimilars Market Players by Market Size
3.1.1 Global Top Biosimilars Market Players by Revenue (2015-2021)
3.1.2 Global Biosimilars Market Revenue Market Share by Players (2015-2021)
3.1.3 Global Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biosimilars Market Concentration Ratio
3.2.1 Global Biosimilars Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biosimilars Market Revenue in 2019
3.3 Biosimilars Market Key Players Head office and Area Served
3.4 Key Players Biosimilars Market Product Solution and Service
3.5 Date of entering into Biosimilars Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2028)
4.1 Global Biosimilars Market Historic Market Size by Type (2015-2021)
4.2 Global Biosimilars Market Forecasted Market Size by Type (2021-2028)
5 Biosimilars Market Breakdown Data by Application (2015-2028)
5.1 Global Biosimilars Market Size by Application (2015-2021)
5.2 Global Biosimilars Market Forecasted Market Size by Application (2021-2028)
6 North America
6.1 North America Biosimilars Market Size (2015-2021)
6.2 Biosimilars Market Key Players in North America (2019-2021)
6.3 North America Biosimilars Market Size by Type (2015-2021)
6.4 North America Biosimilars Market Size by Application (2015-2021)
7 Europe
7.1 Europe Biosimilars Market Size (2015-2021)
7.2 Biosimilars Market Key Players in Europe (2019-2021)
7.3 Europe Biosimilars Market Size by Type (2015-2021)
7.4 Europe Biosimilars Market Size by Application (2015-2021)
8 China
8.1 China Biosimilars Market Size (2015-2021)
8.2 Biosimilars Market Key Players in China (2019-2021)
8.3 China Biosimilars Market Size by Type (2015-2021)
8.4 China Biosimilars Market Size by Application (2015-2021)
9 Japan
9.1 Japan Biosimilars Market Size (2015-2021)
9.2 Biosimilars Market Key Players in Japan (2019-2021)
9.3 Japan Biosimilars Market Size by Type (2015-2021)
9.4 Japan Biosimilars Market Size by Application (2015-2021)
10 Southeast Asia
10.1 Southeast Asia Biosimilars Market Size (2015-2021)
10.2 Biosimilars Market Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia Biosimilars Market Size by Type (2015-2021)
10.4 Southeast Asia Biosimilars Market Size by Application (2015-2021)
11 India
11.1 India Biosimilars Market Size (2015-2021)
11.2 Biosimilars Market Key Players in India (2019-2021)
11.3 India Biosimilars Market Size by Type (2015-2021)
11.4 India Biosimilars Market Size by Application (2015-2021)
12 Central & South America
12.1 Central & South America Biosimilars Market Size (2015-2021)
12.2 Biosimilars Market Key Players in Central & South America (2019-2021)
12.3 Central & South America Biosimilars Market Size by Type (2015-2021)
12.4 Central & South America Biosimilars Market Size by Application (2015-2021)
13 Key Players Profiles
13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Biosimilars Market Introduction
13.4 Biosimilars Market Business (2015-2021)
13.5 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
Table 1. Biosimilars Market Key Market Segments
Table 2. Key Players Covered: Ranking by Biosimilars Market Revenue
Table 3. Ranking of Global Top Biosimilars Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biosimilars Market Size Growth Rate by Type (US$ Million): 2021 VS 2028
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Biosimilars Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Biosimilars Market Players to Combat Covid-19 Impact
Table 10. Global Biosimilars Market Size Growth by Application (US$ Million): 2021 VS 2028
Table 11. Global Biosimilars Market Size by Regions (US$ Million): 2021 VS 2028
Table 12. Global Biosimilars Market Size by Regions (2015-2021) (US$ Million)
Table 13. Global Biosimilars Market Share by Regions (2015-2021)
Table 14. Global Biosimilars Market Forecasted Market Size by Regions (2021-2028) (US$ Million)
Table 15. Global Biosimilars Market Share by Regions (2021-2028)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Biosimilars Market Growth Strategy
Table 20. Main Points Interviewed from Key Biosimilars Market Players
Table 21. Global Biosimilars Market Revenue by Players (2015-2021) (Million US$)
Table 22. Global Biosimilars Market Share by Players (2015-2021)
Table 23. Global Top Biosimilars Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars Market as of 2019)
Table 24. Global Biosimilars Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Biosimilars Market Product Solution and Service
Table 27. Date of entering into Biosimilars Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Biosimilars Market Size by Type (2015-2021) (Million US$)
Table 30. Global Biosimilars Market Size Share by Type (2015-2021)
Table 31. Global Biosimilars Market Revenue Market Share by Type (2021-2028)
Table 31. Global Biosimilars Market Size Share by Application (2015-2021)
Table 33. Global Biosimilars Market Size by Application (2015-2021) (Million US$)
Table 34. Global Biosimilars Market Size Share by Application (2021-2028)
Table 35. North America Key Players Biosimilars Market Revenue (2019-2021) (Million US$)
Table 36. North America Key Players Biosimilars Market Share (2019-2021)
Table 37. North America Biosimilars Market Size by Type (2015-2021) (Million US$)
Table 38. North America Biosimilars Market Share by Type (2015-2021)
Table 39. North America Biosimilars Market Size by Application (2015-2021) (Million US$)
Table 40. North America Biosimilars Market Share by Application (2015-2021)
Table 41. Europe Key Players Biosimilars Market Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players Biosimilars Market Share (2019-2021)
Table 43. Europe Biosimilars Market Size by Type (2015-2021) (Million US$)
Table 44. Europe Biosimilars Market Share by Type (2015-2021)
Table 45. Europe Biosimilars Market Size by Application (2015-2021) (Million US$)
Table 46. Europe Biosimilars Market Share by Application (2015-2021)
Table 47. China Key Players Biosimilars Market Revenue (2019-2021) (Million US$)
Table 48. China Key Players Biosimilars Market Share (2019-2021)
Table 49. China Biosimilars Market Size by Type (2015-2021) (Million US$)
Table 50. China Biosimilars Market Share by Type (2015-2021)
Table 51. China Biosimilars Market Size by Application (2015-2021) (Million US$)
Table 52. China Biosimilars Market Share by Application (2015-2021)
Table 53. Japan Key Players Biosimilars Market Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players Biosimilars Market Share (2019-2021)
Table 55. Japan Biosimilars Market Size by Type (2015-2021) (Million US$)
Table 56. Japan Biosimilars Market Share by Type (2015-2021)
Table 57. Japan Biosimilars Market Size by Application (2015-2021) (Million US$)
Table 58. Japan Biosimilars Market Share by Application (2015-2021)
Table 59. Southeast Asia Key Players Biosimilars Market Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players Biosimilars Market Share (2019-2021)
Table 61. Southeast Asia Biosimilars Market Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia Biosimilars Market Share by Type (2015-2021)
Table 63. Southeast Asia Biosimilars Market Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia Biosimilars Market Share by Application (2015-2021)
Table 65. India Key Players Biosimilars Market Revenue (2019-2021) (Million US$)
Table 66. India Key Players Biosimilars Market Share (2019-2021)
Table 67. India Biosimilars Market Size by Type (2015-2021) (Million US$)
Table 68. India Biosimilars Market Share by Type (2015-2021)
Table 69. India Biosimilars Market Size by Application (2015-2021) (Million US$)
Table 70. India Biosimilars Market Share by Application (2015-2021)
Table 71. Central & South America Key Players Biosimilars Market Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players Biosimilars Market Share (2019-2021)
Table 73. Central & South America Biosimilars Market Size by Type (2015-2021) (Million US$)
Table 74. Central & South America Biosimilars Market Share by Type (2015-2021)
Table 75. Central & South America Biosimilars Market Size by Application (2015-2021) (Million US$)
Table 76. Central & South America Biosimilars Market Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Biosimilars Market Business (2015-2021) (Million US$)
Table 81. Recent Development
List of Figures
Figure 1. Global Biosimilars Market Share by Type: 2021 VS 2028
Figure 2. Global Biosimilars Market Share by Application: 2021 VS 2028
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Biosimilars Market Report Years Considered
Figure 8. Global Biosimilars Market Size YoY Growth 2015-2028 (US$ Million)
Figure 9. Global Biosimilars Market Share by Regions: 2021 VS 2028
Figure 10. Global Biosimilars Market Share by Regions (2021-2028)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Biosimilars Market Share by Players in 2019
Figure 13. Global Top Biosimilars Market Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in Biosimilars Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Biosimilars Market Revenue in 2019
Figure 15. North America Biosimilars Market Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe Biosimilars Market Size YoY Growth (2015-2021) (Million US$)
Figure 17. China Biosimilars Market Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan Biosimilars Market Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia Biosimilars Market Size YoY Growth (2015-2021) (Million US$)
Figure 20. India Biosimilars Market Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America Biosimilars Market Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
